Patrick S. Ward, Ph.D.
Affiliations: | 2013 | Cell and Molecular Biology | University of Pennsylvania, Philadelphia, PA, United States |
Google:
"Patrick Ward"Mean distance: 25144.9
Parents
Sign in to add mentorGarret A. FitzGerald | grad student | 2013 | Penn | |
(The common feature of cancer-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to the oncometabolite 2-hydroxyglutarate.) | ||||
Vamsi Mootha | post-doc | Harvard (Cell Biology Tree) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Peterson AA, Rangwala AM, Thakur MK, et al. (2022) Discovery and molecular basis of subtype-selective cyclophilin inhibitors. Nature Chemical Biology |
Rath S, Sharma R, Gupta R, et al. (2020) MitoCarta3.0: an updated mitochondrial proteome now with sub-organelle localization and pathway annotations. Nucleic Acids Research |
Lu C, Venneti S, Akalin A, et al. (2013) Induction of sarcomas by mutant IDH2. Genes & Development. 27: 1986-98 |
Ward PS, Lu C, Cross JR, et al. (2013) The potential for isocitrate dehydrogenase mutations to produce 2-hydroxyglutarate depends on allele specificity and subcellular compartmentalization. The Journal of Biological Chemistry. 288: 3804-15 |
Turcan S, Rohle D, Goenka A, et al. (2012) IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype. Nature. 483: 479-83 |
Wise DR, Ward PS, Shay JE, et al. (2011) Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of α-ketoglutarate to citrate to support cell growth and viability. Proceedings of the National Academy of Sciences of the United States of America. 108: 19611-6 |